Towards a shared language for pharmacists prescribing: Why terminology matters

Area of Science:

• Health Policy
• Pharmacy Practice
• Regulatory Science

Background:

• Pharmacist prescribing is rapidly expanding globally to enhance healthcare access and optimize medication use.
• Inconsistent and ambiguous terminology in policy documents impedes effective development and evaluation of pharmacist prescribing initiatives.
• Current terms for prescribing, scope of practice, and pharmacist roles are variably applied, causing confusion.

Purpose of the Study:

• To analyze the concept of prescribing as a regulated act.
• To highlight the need for standardized terminology in pharmacist prescribing.
• To advocate for a shared language to improve policy, governance, and patient care.

Main Methods:

• Conceptual analysis of prescribing as a regulated act.
• Discussion of current terminology and its implications.
• Argument for a standardized, cross-professional language.

Main Results:

• Prescribing is defined as a regulated act with four key elements: medicine, condition, prescriber, and regulatory authority.
• Ambiguous terms like 'minor ailments' and 'independent prescribing' obscure accountability and complicate interprofessional boundaries.
• Pharmacy-specific labels hinder coherent regulatory governance and system integration.

Conclusions:

• A standardized, cross-professional terminology for prescribing is essential for effective policy design and evaluation.
• Clarifying the conceptual and regulatory meaning of prescribing is a prerequisite for expanding community pharmacy services.
• A shared language will enhance transparency, improve system integration, and enable robust assessment of safety and equity.